img

Global mRNA Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global mRNA Vaccines Market Research Report 2024

When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine.
According to MRA Research’s new survey, global mRNA Vaccines market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA Vaccines market research.
Key companies engaged in the mRNA Vaccines industry include MODERNA, Pfizer, Zydus Cadila, Fosun Pharmaceutical, CureVac and Stemirna, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of mRNA Vaccines were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole mRNA Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global mRNA Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


MODERNA
Pfizer
Zydus Cadila
Fosun Pharmaceutical
CureVac
Stemirna
Segment by Type
Being Developed
Preclinical
Clinical I
Clinical II

Segment by Application


COVID-19
Cancer
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The mRNA Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Being Developed
1.2.3 Preclinical
1.2.4 Clinical I
1.2.5 Clinical II
1.3 Market by Application
1.3.1 Global mRNA Vaccines Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 COVID-19
1.3.3 Cancer
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccines Market Perspective (2018-2033)
2.2 mRNA Vaccines Growth Trends by Region
2.2.1 Global mRNA Vaccines Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 mRNA Vaccines Historic Market Size by Region (2018-2023)
2.2.3 mRNA Vaccines Forecasted Market Size by Region (2024-2033)
2.3 mRNA Vaccines Market Dynamics
2.3.1 mRNA Vaccines Industry Trends
2.3.2 mRNA Vaccines Market Drivers
2.3.3 mRNA Vaccines Market Challenges
2.3.4 mRNA Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccines Players by Revenue
3.1.1 Global Top mRNA Vaccines Players by Revenue (2018-2023)
3.1.2 Global mRNA Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccines Revenue
3.4 Global mRNA Vaccines Market Concentration Ratio
3.4.1 Global mRNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines Revenue in 2023
3.5 mRNA Vaccines Key Players Head office and Area Served
3.6 Key Players mRNA Vaccines Product Solution and Service
3.7 Date of Enter into mRNA Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccines Breakdown Data by Type
4.1 Global mRNA Vaccines Historic Market Size by Type (2018-2023)
4.2 Global mRNA Vaccines Forecasted Market Size by Type (2024-2033)
5 mRNA Vaccines Breakdown Data by Application
5.1 Global mRNA Vaccines Historic Market Size by Application (2018-2023)
5.2 Global mRNA Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America mRNA Vaccines Market Size (2018-2033)
6.2 North America mRNA Vaccines Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America mRNA Vaccines Market Size by Country (2018-2023)
6.4 North America mRNA Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Vaccines Market Size (2018-2033)
7.2 Europe mRNA Vaccines Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe mRNA Vaccines Market Size by Country (2018-2023)
7.4 Europe mRNA Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccines Market Size (2018-2033)
8.2 Asia-Pacific mRNA Vaccines Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific mRNA Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Vaccines Market Size (2018-2033)
9.2 Latin America mRNA Vaccines Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America mRNA Vaccines Market Size by Country (2018-2023)
9.4 Latin America mRNA Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccines Market Size (2018-2033)
10.2 Middle East & Africa mRNA Vaccines Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa mRNA Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MODERNA
11.1.1 MODERNA Company Detail
11.1.2 MODERNA Business Overview
11.1.3 MODERNA mRNA Vaccines Introduction
11.1.4 MODERNA Revenue in mRNA Vaccines Business (2018-2023)
11.1.5 MODERNA Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer mRNA Vaccines Introduction
11.2.4 Pfizer Revenue in mRNA Vaccines Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Detail
11.3.2 Zydus Cadila Business Overview
11.3.3 Zydus Cadila mRNA Vaccines Introduction
11.3.4 Zydus Cadila Revenue in mRNA Vaccines Business (2018-2023)
11.3.5 Zydus Cadila Recent Development
11.4 Fosun Pharmaceutical
11.4.1 Fosun Pharmaceutical Company Detail
11.4.2 Fosun Pharmaceutical Business Overview
11.4.3 Fosun Pharmaceutical mRNA Vaccines Introduction
11.4.4 Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2018-2023)
11.4.5 Fosun Pharmaceutical Recent Development
11.5 CureVac
11.5.1 CureVac Company Detail
11.5.2 CureVac Business Overview
11.5.3 CureVac mRNA Vaccines Introduction
11.5.4 CureVac Revenue in mRNA Vaccines Business (2018-2023)
11.5.5 CureVac Recent Development
11.6 Stemirna
11.6.1 Stemirna Company Detail
11.6.2 Stemirna Business Overview
11.6.3 Stemirna mRNA Vaccines Introduction
11.6.4 Stemirna Revenue in mRNA Vaccines Business (2018-2023)
11.6.5 Stemirna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global mRNA Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Being Developed
Table 3. Key Players of Preclinical
Table 4. Key Players of Clinical I
Table 5. Key Players of Clinical II
Table 6. Global mRNA Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global mRNA Vaccines Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 8. Global mRNA Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global mRNA Vaccines Market Share by Region (2018-2023)
Table 10. Global mRNA Vaccines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global mRNA Vaccines Market Share by Region (2024-2033)
Table 12. mRNA Vaccines Market Trends
Table 13. mRNA Vaccines Market Drivers
Table 14. mRNA Vaccines Market Challenges
Table 15. mRNA Vaccines Market Restraints
Table 16. Global mRNA Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global mRNA Vaccines Market Share by Players (2018-2023)
Table 18. Global Top mRNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines as of 2023)
Table 19. Ranking of Global Top mRNA Vaccines Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by mRNA Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players mRNA Vaccines Product Solution and Service
Table 23. Date of Enter into mRNA Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global mRNA Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global mRNA Vaccines Revenue Market Share by Type (2018-2023)
Table 27. Global mRNA Vaccines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global mRNA Vaccines Revenue Market Share by Type (2024-2033)
Table 29. Global mRNA Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global mRNA Vaccines Revenue Market Share by Application (2018-2023)
Table 31. Global mRNA Vaccines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global mRNA Vaccines Revenue Market Share by Application (2024-2033)
Table 33. North America mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 34. North America mRNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America mRNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. Europe mRNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe mRNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific mRNA Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 40. Asia-Pacific mRNA Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific mRNA Vaccines Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 43. Latin America mRNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America mRNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 46. Middle East & Africa mRNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa mRNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 48. MODERNA Company Detail
Table 49. MODERNA Business Overview
Table 50. MODERNA mRNA Vaccines Product
Table 51. MODERNA Revenue in mRNA Vaccines Business (2018-2023) & (US$ Million)
Table 52. MODERNA Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer mRNA Vaccines Product
Table 56. Pfizer Revenue in mRNA Vaccines Business (2018-2023) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Zydus Cadila Company Detail
Table 59. Zydus Cadila Business Overview
Table 60. Zydus Cadila mRNA Vaccines Product
Table 61. Zydus Cadila Revenue in mRNA Vaccines Business (2018-2023) & (US$ Million)
Table 62. Zydus Cadila Recent Development
Table 63. Fosun Pharmaceutical Company Detail
Table 64. Fosun Pharmaceutical Business Overview
Table 65. Fosun Pharmaceutical mRNA Vaccines Product
Table 66. Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2018-2023) & (US$ Million)
Table 67. Fosun Pharmaceutical Recent Development
Table 68. CureVac Company Detail
Table 69. CureVac Business Overview
Table 70. CureVac mRNA Vaccines Product
Table 71. CureVac Revenue in mRNA Vaccines Business (2018-2023) & (US$ Million)
Table 72. CureVac Recent Development
Table 73. Stemirna Company Detail
Table 74. Stemirna Business Overview
Table 75. Stemirna mRNA Vaccines Product
Table 76. Stemirna Revenue in mRNA Vaccines Business (2018-2023) & (US$ Million)
Table 77. Stemirna Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global mRNA Vaccines Market Share by Type: 2023 VS 2033
Figure 3. Being Developed Features
Figure 4. Preclinical Features
Figure 5. Clinical I Features
Figure 6. Clinical II Features
Figure 7. Global mRNA Vaccines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global mRNA Vaccines Market Share by Application: 2023 VS 2033
Figure 9. COVID-19 Case Studies
Figure 10. Cancer Case Studies
Figure 11. Infectious Disease Treatment MRNA Vaccine Case Studies
Figure 12. Infection Prevention MRNA Vaccine Case Studies
Figure 13. mRNA Vaccines Report Years Considered
Figure 14. Global mRNA Vaccines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global mRNA Vaccines Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 16. Global mRNA Vaccines Market Share by Region: 2023 VS 2033
Figure 17. Global mRNA Vaccines Market Share by Players in 2023
Figure 18. Global Top mRNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by mRNA Vaccines Revenue in 2023
Figure 20. North America mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America mRNA Vaccines Market Share by Country (2018-2033)
Figure 22. United States mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe mRNA Vaccines Market Share by Country (2018-2033)
Figure 26. Germany mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific mRNA Vaccines Market Share by Region (2018-2033)
Figure 34. China mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America mRNA Vaccines Market Share by Country (2018-2033)
Figure 42. Mexico mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa mRNA Vaccines Market Share by Country (2018-2033)
Figure 46. Turkey mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia mRNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. MODERNA Revenue Growth Rate in mRNA Vaccines Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in mRNA Vaccines Business (2018-2023)
Figure 50. Zydus Cadila Revenue Growth Rate in mRNA Vaccines Business (2018-2023)
Figure 51. Fosun Pharmaceutical Revenue Growth Rate in mRNA Vaccines Business (2018-2023)
Figure 52. CureVac Revenue Growth Rate in mRNA Vaccines Business (2018-2023)
Figure 53. Stemirna Revenue Growth Rate in mRNA Vaccines Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries